Anavex Life Sciences Corp.
AVXL | NASDAQ
$2.46
+$0.06 (+2.50%)
Sep 22, 2026, 10:37 AM ET · Market open
TTM Period Ending | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -34.09M | -39.95M | -46.38M | -48.17M | -47.14M | -46.49M | -43M | -41.53M | -40.59M | -43.16M | -47.51M | -51.65M | -52.74M | -50.07M | -47.98M | -45.41M | -43.22M | -40.94M | -37.91M | -32.16M | -28.46M | -27.54M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 9.15M | 10.6M | 11.55M | 9.84M | 8M | 9.21M | 9.44M | 10.61M | 11.99M | 13.31M | 16.37M | 19.23M | 19.35M | 19.82M | 18.38M | 15.49M | 13.79M | 11.2M | 8.23M | 5.74M | 4.7M | 4.55M |
Other Working Capital | -6.35M | -4.51M | -478K | -2.91M | 5.2M | 403K | -2.81M | 1.12M | -2.27M | 142.77K | 1.52M | 179.93K | 1.78M | 1.79M | 331.57K | 1.06M | 1.26M | 2.1M | 2.83M | 2.31M | 1.45M | 1.32M |
Other Non-Cash Items | 5.34M | n/a | n/a | 59K | n/a | n/a | n/a | -58.5K | 500 | 845.5K | 845.5K | 845K | 845K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -8.62M | -4.73M | -4.22M | 1.17M | 9.32M | 1.67M | 2.75M | 971.25K | -3.87M | -308.75K | 2.5M | 5.6M | 7.16M | 3.72M | 5.36M | 2.05M | 1.09M | 3.72M | -706.44K | -2.55M | -1.72M | -441.45K |
Operating Cash Flow | -28.22M | -34.08M | -39.04M | -37.1M | -29.81M | -35.61M | -30.81M | -30M | -32.48M | -29.31M | -27.79M | -25.98M | -25.38M | -26.53M | -24.24M | -27.87M | -28.34M | -26.01M | -30.38M | -28.96M | -25.49M | -23.43M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.71M | -2.71M | -2.71M | -2.26M | 444K | 444K | 444K | 1.31M | 1.34M | 1.52M | 1.52M | 650.43K | 509.33K | 76.53K | 303.31K | 2.53M | 135.03K | 513.89K | 23.65K | -2.58M | -539.66K | -667.22K |
Financial Cash Flow | 44.2M | 45.05M | 9.43M | -494K | 6.2M | 12.62M | 11.98M | 13.94M | 18.4M | 29.45M | 29.65M | 27.6M | 25.5M | 19.01M | 21.29M | 23.51M | 105.82M | 129.8M | 153.24M | 158.9M | 74.78M | 43.33M |
Net Cash Flow | -115.77M | 10.97M | -29.61M | -37.59M | -23.62M | -22.99M | -18.84M | -16.06M | -14.08M | 142.84K | 1.87M | 1.62M | 124.31K | -7.52M | -2.95M | -4.36M | 77.48M | 103.79M | 122.86M | 129.94M | 49.3M | 19.9M |
Free Cash Flow | -28.22M | -34.08M | -39.04M | -37.1M | -29.81M | -35.61M | -30.81M | -30M | -32.48M | -29.31M | -27.79M | -25.98M | -25.38M | -26.53M | -24.24M | -27.87M | -28.34M | -26.01M | -30.38M | -28.96M | -25.49M | -23.43M |
Adj. Free Cash Flow | -37.37M | -44.68M | -50.59M | -46.94M | -37.82M | -44.82M | -40.25M | -40.62M | -44.47M | -42.62M | -44.16M | -45.21M | -44.73M | -46.35M | -42.62M | -43.36M | -42.13M | -37.21M | -38.62M | -34.7M | -30.18M | -27.99M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -28.22M | -34.08M | -39.04M | -37.1M | -29.81M | -35.61M | -30.81M | -30M | -32.48M | -29.31M | -27.79M | -25.98M | -25.38M | -26.53M | -24.24M | -27.87M | -28.34M | -26.01M | -30.38M | -28.96M | -25.49M | -23.43M |
Add to Watchlist
Select watchlists to add or remove AVXL